Isala Zwolle

Zwolle 8025 BP

2 studies enrolling now · 9 studies all time

What they study most

Bradycardia, Breast Neoplasms, Cardiac Rhythm Disorder, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Heart Failure, Hypertension, Injury of Ureter During Surgery (Disorder), Lower Urinary Tract Symptoms, Myocardial Infarction, PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC, Tachycardia

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery — Recruiting now
• Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) — Running, not enrolling
• The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System — Completed
• INTIBIA Pivotal Study — Running, not enrolling
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Extravascular ICD Pivotal Study — Completed
• Attain Stability™ Quad Clinical Study — Completed
• LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment — Completed